Pharmaceutical Intermediates Daptomycin Raw Material Antibiotic Daptomycin Powder Purity Daptomycin

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Model NO.: Dsung-Daptomycin
• Product Name: Daptomycin
• Name: Daptomycin Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antibiotic
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 103060-53-3
• Mf: C72h101n17o26
• MW: 1620.67000
• Boiling Point: 2078.2 C at 760 Mmhg
• Density: 1.45 g/cm3
• Refractive Index: 1.638
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 10kg/Month

Product Description

Pharmaceutical Intermediates Daptomycin Raw Material Antibiotic Daptomycin Powder Purity Daptomycin

 

Product Description

Product Details

Product Name	Daptomycin
CAS No.	103060-53-3
Purity	99%
MW	1620.67000
Appearance and shape	White Powder

Daptomycin is the first entry of a new class of cyclic lipopeptide antibiotics that disrupts multiple aspects of bacterial membrane function including disruption of membrane potential and amino acid transport, inhibition of lipoteichoic acid synthesis and inhibition of peptidoglycan synthesis. It is indicated for the treatment of complicated skin and skinstructure infections (cSSSI) caused by a range of Gram-positive bacteria. This is distinct from previous classes of antibiotics that inhibit bacterial cell wall biosynthesis, bacterial DNA replication, and folate coenzyme biosynthesis. Due to this unique mechanism, cross-resistance has not been noted with any other class of antibiotics.

Application & Function

Function of Daptomycin 
Cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.
Daptomycin exhibits Ca-dependent depolarisation of the bacterial membrane resulting in loss of membrane potential leading to inhibition of DNA, RNA and protein synthesis which results in cell death.
Application of Daptomycin 
Pharmaceutical intermediates, used in the treatment of concurrent skin and skin structure infections caused by a number of Gram-positive caused by susceptible strains.

Specification